Plasmodium sporozoites invade host hepatocytes and develop as liver stages (LS) before the onset of erythrocytic infection and malaria symptoms. LS are clinically silent, and constitute ideal targets for causal prophylactic drugs and vaccines. The molecular and cellular mechanisms underlying LS development remain poorly characterized. Here we describe a conserved Plasmodium asparagine-rich protein that is specifically expressed in sporozoites and liver stages. Gene disruption in Plasmodium berghei results in complete loss of sporozoite infectivity to rodents, due to early developmental arrest after invasion of hepatocytes. Mutant sporozoites productively invade host cells by forming a parasitophorous vacuole (PV), but subsequent remodelling of the membrane of the PV (PVM) is impaired as a consequence of dramatic down-regulation of genes encoding PVM-resident proteins. These early arrested mutants confer only limited protective immunity in immunized animals. Our results demonstrate the role of an asparagine-rich protein as a key regulator of Plasmodium sporozoite gene expression and LS development, and suggest a requirement of partial LS maturation to induce optimal protective immune responses against malaria pre-erythrocytic stages. These findings have important implications for the development of genetically attenuated parasites as a vaccine approach.
Introduction
With over 300 million cases each year, malaria remains the most important vector-borne infectious disease, severely affecting human health and social and economical development in endemic areas [1] . The malaria parasite Plasmodium is transmitted via the bite of a female Anopheles mosquito, which releases sporozoite stages into the skin [2] . Sporozoites enter the blood stream and, upon reaching the liver hepatocytes, transform into liver stages (LS), also called exoerythrocytic forms (EEFs). LS grow, undergoing multiple rounds of nuclear divisions and ultimately produce thousands of first generation merozoites, which then commence the development of the pathogenic erythrocytic stages [3] .
Plasmodium sporozoites invade hepatocytes by forming a membrane-bound specialized compartment, the parasitophorous vacuole (PV), where they differentiate into LS. LS are highly metabolically active, undergoing one of the fastest growth rates among eukaryotic cells. LS development is a complex process that includes initial sporozoite transformation, remodeling of the PV membrane (PVM), onset of mitotic divisions and parasite growth, before eventual merozoite formation and egress. LS constitute transition stages between sporozoites and merozoites, as reflected on transcriptome and proteome levels [4] . How the parasite regulates its gene expression to accomplish this critical transition phase remains elusive.
LS represent potential targets for causal prophylactic drugs and vaccines. In particular, immunization with radiation-attenuated parasites (RAPs) can induce sterile protection against sporozoite infection [5] . The recent demonstration that genetically attenuated parasites (GAPs) also confer protective immunity in mouse models created a renewed interest in whole parasite vaccine approaches against malaria [6, 7, 8] . Protective immunity induced by RAPs and GAPs relies primarily on CD8+ T cell responses against infected hepatocytes [9, 10, 11, 12, 13, 14, 15] , but the antigenic specificity of protective CD8 + T cells is unknown. Because of the high A/T nucleotide content of Plasmodium DNA, many malarial proteins contain low complexity regions (LCR). Interestingly, the composition of these LCR is biased towards an over-representation of asparagines as compared to lysines, although both share the same codon AT-richness, suggesting a phenotypic selection [16] . Still, the role of asparagine-rich proteins in Plasmodium remains unknown. Here we focused on a conserved Plasmodium asparagine-rich protein that is specifically expressed in sporozoites and early LS, and was therefore termed SLARP (Sporozoite and Liver stage Asparagine-Rich Protein). Parasites lacking SLARP develop normally in the mosquito and invade mammalian hepatocytes as efficiently as wild type parasites. Nevertheless, they are completely arrested at a very early step of LS development, prior to remodelling of the PVM and onset of nuclear divisions.
Results

SLARP/S22 encodes a conserved asparagine-rich protein
Plasmodium liver stages (LS) are amongst the least known stages of the parasite life cycle. In an attempt to identify potential candidate genes specifically expressed in pre-erythrocytic stages, we previously used a suppressive subtractive hybridization screen in P. yoelii, which enabled the identification of 25 S genes expressed in sporozoites but not in blood stages [17] . One of these genes (S22) encodes an asparagine-rich protein that, as shown below, is specifically expressed in sporozoites and early/mid LS, and was therefore termed SLARP (Sporozoite and Liver stage AsparagineRich Protein). The SLARP gene and its genomic organization are conserved among Plasmodium species, including P. falciparum (PfSLARP/PF11_0480), P. vivax (PvSLARP/Pv092945), P. knowlesi (PkSLARP/PKH_094440), P. yoelii (PySLARP/Genbank accession no. EU579525) and P. berghei (PbSLARP/Genbank accession no. EU579524). SLARP contains one large and two small exons, encoding a 2940-3305 amino acids protein with no apparent similarities to known proteins (Fig. 1) . Remarkably, SLARP protein contains large stretches of low complexity, making up ,40% of its sequence in P. falciparum and ,30% in P. berghei and P. yoelii, with an overrepresentation of asparagine residues.
SLARP is expressed in sporozoites and early/mid LS According to P. falciparum DNA microarray data, PfSLARP transcripts are readily detected in sporozoites but not in blood stages [18] , consistent with the gene expression profiling in P. yoelii [17] . We investigated the expression of SLARP in different stages of the rodent parasite P. berghei using RT-PCR. SLARP transcripts were found in salivary gland sporozoites, as observed with TRAP, but were barely detectable in mosquito midgut oocysts ( Fig. 2A) . Sequencing of the RT-PCR products confirmed the predicted exon-intron gene structure (data not shown). SLARP expression was also detected in early (24h) and mid (48h) LS developing in vitro in HepG2 cells, but not in late LS (72h) (Fig. 2B) . The final maturation of P. berghei LS in vitro is characterized by the appearance of detached infected cells, also called merosomes, in the culture supernatants [19] . SLARP expression was not detectable in merosomes, or in blood stages, whereas a control transcript (P. berghei glyceraldehyde 3-phosphate dehydrogenase, GAPDH) was detected throughout liver stage development (Fig. 2B) .
In order to confirm SLARP expression timing and determine the subcellular localization of the protein, we generated a parasite line expressing the endogenous copy of SLARP fused in frame at its 39 end to the coding sequence of the red fluorescent protein mCherry [20] (Fig. 2C) . Transfection was performed in P. berghei ANKA parasites constitutively expressing GFP [21] , leading to green fluorescent parasites that express a red fluorescent SLARP (PbSLARP/mCherry). Genotyping confirmed the desired integration event, and PCR on cDNA from PbSLARP/mCherry sporozoites showed expression and correct splicing of the fusion transcript (data not shown). We next assessed the expression of the fusion protein in different stages of PbSLARP/mCherry parasites by direct detection of mCherry fluorescence by confocal microscopy. As predicted, no red fluorescence was detectable in blood stages or oocysts of PbSLARP/mCherry parasites (data not shown). In contrast, mCherry could be detected in sporozoites and LS (Fig. 2D) , in good agreement with the RT-PCR data. The mCherry signal in PbSLARP/mCherry parasites was rather weak, but was clearly distinguishable from background, and was not observed in WT parasites (Fig. 2D) . Interestingly, mCherry fluorescence had a similar distribution as the Hoechst staining in PbSLARP/mCherry parasites (Fig. 2D) . Although we could not determine precisely using confocal microscopy whether SLARP/ mCherry localizes inside the nucleus or at its periphery, our data clearly indicate that the fusion protein associates with the parasite nucleus. Closer examination of the PbSLARP primary structure revealed two potential bipartite nuclear localization signals (NLS) that are conserved in SLARP from other Plasmodium species and may contribute to the nuclear localization of the protein (Fig. 1B) . Together our findings show that Plasmodium encodes a sporozoite and liver stage-specific asparagine-rich protein that seems to localize predominantly in the parasite nuclear region.
SLARP gene deletion in P. berghei
To study the importance of SLARP during the Plasmodium life cycle, we generated loss-of-function P. berghei parasites. We used a replacement strategy (Fig. 3A) to disrupt the endogenous SLARP gene copy by double crossover homologous recombination [22] . A targeting construct comprising 59 and 39 fragments of SLARP flanking the pyrimethamine-resistance cassette was used for positive selection after parasite transfection. The parental blood stage population from a successful transfection was used to isolate three independent disruptant clones, two of which were subsequently used for phenotypical analysis (slarp(-)cl1 and slarp(-)cl3). Occurrence of the double crossover was confirmed by PCR in pyrimethamine-resistant parasites, using primers specific for the 59 and the 39 end recombination events, respectively (Fig. 3B) . The wild type locus was not detected in slarp(-)cl1 and slarp(-)cl3, confirming the homogeneity of the expected recombination. We also performed RT-PCR on RNA from salivary gland sporozoites of wild type and slarp(-) parasites. While TRAP control transcripts were detected in all parasite populations, SLARP transcripts were detected only in WT, but not in slarp(-) parasites, confirming the successful depletion of SLARP in the mutants (Fig. 3C) .
SLARP-deficient sporozoites are non-infective to rodents
We next examined the phenotype of slarp(-) parasites during the P. berghei life cycle. As expected from successful disruption of the SLARP gene in blood stages, slarp(-) clones were indistinguishable from WT parasites in development and growth of asexual stages (data not shown). slarp(-) parasites produced gametocytes and exflagellation of male gametocytes was similar to WT parasites (data not shown). Transmission to Anopheles stephensi mosquitoes and oocyst development were also normal when compared to WT parasites. slarp(-) oocysts produced sporozoites, which invaded mosquito salivary glands as efficiently as WT parasites ( Table 1) . Based on these findings we conclude that SLARP is dispensable for the P. berghei life cycle in the mosquito.
We further investigated slarp(-) sporozoite in vivo infectivity to highly susceptible young Sprague-Dawley rats and C57BL/6 mice. In contrast to WT sporozoites, which consistently induced blood stage infection, none of the animals inoculated with slarp(-) sporozoites developed a patent blood stage infection, even after intravenous injection of very high numbers of sporozoites (up to 500,000), or when sporozoites were inoculated through mosquito bites, the natural transmission route ( Table 2 ). These data demonstrate that disruption of SLARP in P. berghei abolishes sporozoite infectivity to rodents.
Depletion of SLARP results in early developmental arrest after sporozoite invasion
Combined with the absence of a defect in blood stage multiplication, the lack of infectivity of slarp(-) sporozoites suggested a defect in sporozoite invasion and/or LS development. To distinguish which step was affected, we analyzed slarp(-) sporozoite infection in vitro in HepG2 cells. Sporozoites invade host cells by two alternative routes, cell traversal or productive infection [23] . Cell traversal is associated with host cell membrane rupture followed by sporozoite migration through the host cell cytoplasm, and is required for sporozoite migration in the skin and through the liver sinusoidal barrier [24, 25, 26, 27] . Productive infection of hepatocytes requires the formation of a PV, in which LS development takes place [23] . We analyzed these two different invasion modes in vitro with WT and slarp(-) sporozoites. As shown using a dextran-based wound and repair assay [23] , cell traversal activity was not impaired in slarp(-) parasites, with similar numbers of dextran-positive cells as observed with WT ( Table 1 ). The number of intracellular sporozoites early after infection was similar in slarp(-) clones and WT ( Fig. 4A and Table 1) , and most sporozoites of WT (81,9+/20,4%, n = 204) and slarp(-) (81,5+/ 20,8%, n = 211) were found in dextran-negative cells, providing indirect evidence that slarp(-) sporozoites are capable of productively entering the host cell. Staining with the cholesterol-binding agent filipin [28] confirmed the presence of a PVM in both WT and slarp(-) sporozoite-infected cells (see Fig. 5A -B).
The number of WT LS in the cultures was constant from 6 until 48 hours post-infection, followed by a marked decrease at 72 hours (Fig. 4A) , which was concomitant with the appearance in the culture supernatants of detached infected cells (merosomes). Morphologically, WT parasite development was characterized by an increase in size over time and the occurrence of multiple nuclear divisions, as shown by Hoechst staining (Fig. 4B and 4C ). At 72 hours post-infection, most WT parasites remaining in the culture monolayers displayed the typical aspect of mature segmented parasites (Fig. 4B) . In contrast to WT parasites, the number of slarp(-) LS decreased over time in vitro, and we did not observe detachment of infected cells and release of merosomes (Fig. 4A) . Furthermore, slarp(-) LS remained very small throughout the culture time, around 3-4 mm, which roughly corresponds to the size of 12-18h WT parasites (Fig. 4B ). Most slarp(-) parasites were blocked at the one nucleus stage, even at late time points of infection ( Fig. 4C) . Notably, nuclear material was no longer detectable in a significant proportion of the mutant parasites, and this proportion increased over time (Fig. 4C) . Taken together, these results demonstrate a severe defect of parasite replication in SLARPdeficient LS, which do not survive in vitro.
Remodelling of the PVM is impaired in SLARP-deficient parasites
The early post-invasion defect of LS development and the PVM-positive filipin stain observed in slarp(-) parasites prompted us to analyze the expression of the up-regulated in infective sporozoites (UIS)-4 protein, which specifically localizes to the PVM early after invasion [6] . Invaded WT sporozoites displayed a strong UIS4 staining that extended to the host cell cytoplasm and colocalized with filipin ( Fig. 5A) , consistent with PVM localization. Importantly, no UIS4 or filipin staining of sporozoites was observed in infected dextran-positive cells (Fig. 5A) . This confirms that UIS4 and filipin are specific markers of PVM formation, and further suggests that the bulk of UIS4 found in intracellular parasites is synthesized after sporozoite productive invasion. Remarkably, although slarp(-) sporozoites formed a PV inside host cells, as demonstrated by the absence of dextran uptake by the host cell and by staining of sporozoites by filipin, they lacked peripheral UIS4 staining (Fig. 5A-B) . Instead, only weak internal UIS4 staining was sometimes observed in the mutant parasites, which likely corresponds to residual protein originating from sporozoites. We also analyzed expression of the Exported Protein-1 (EXP1), a mid/late LS antigen initially not present in sporozoites but expressed in LS, where, like UIS4, it localizes to the PVM [19, 29, 30] . EXP1 was detected by immunofluorescence in WT LS, with a circumferential staining consistent with PVM localization (Fig. 5C ). As expected, EXP1 was not detected by immunofluorescence in salivary gland sporozoites or intracellular (BS). gDNA, genomic DNA; +, with reverse transcription; 2, without reverse transcription. (C) Insertion strategy to generate the SLARP/ mCherry parasites. The PbSLARP genomic locus was targeted with an integration plasmid containing a 39 terminal fragment of the SLARP gene fused in frame to the mCherry coding sequence (M), the 39 UTR of PbDHFR/TS (39UTR) and the TgDHFR/TS selectable marker. Upon a single crossover event, the region of homology is duplicated, resulting in a functional, endogenous PbSLARP copy tagged with mCherry, followed by a truncated and non-expressed copy. (D) Detection of the SLARP/ mCherry fusion protein (red) was analyzed directly by confocal fluorescence microscopy of sporozoites isolated from mosquito salivary glands (SPZ), or intracellular parasites 2h30 and 24 hours post-infection (p.i.) of HepG2 cells with SLARP/mCherry or WT P. berghei parasites constitutively expressing GFP (green). Nuclei were stained with Hoechst 33342 (blue). Bar = 5 mm. Note that the red fluorescent structures (indicated by asteriks) observed around SLARP/mCherry or WT parasites were also found in non-infected HepG2 cells, and correspond to host autofluorescent material unrelated to mCherry fluorescence (indicated by arrowheads), which was only observed inside SLARP/mCherry (but not WT) parasites. doi:10.1371/journal.ppat.1000086.g002 sporozoites 6 hours post-infection (data not shown). In contrast with WT parasites, we consistently failed to detect EXP1 in slarp(-) LS (Fig. 5C-D) .
Deletion of SLARP causes a dramatic decrease of UIS3 and UIS4 transcript abundance in sporozoites
In order to determine whether the absence of UIS4 protein in invaded sporozoites was due to a defect in UIS4 gene expression, we analyzed steady state transcript abundance in slarp(-) versus WT parasites, using quantitative PCR (RT-qPCR). We observed a dramatic reduction (,80 fold) of UIS4 transcript abundance in slarp(-) parasites as compared to WT parasites 6 hours postinfection, while control transcripts for GAPDH and heat shock protein 70 (HSP70) were not affected (Fig. 6A) . RT-qPCR also demonstrated a ,20 fold reduction in the level of transcripts for UIS3, another PVM-resident protein [7, 13] , whereas EXP1 expression was only slightly reduced (,2 fold) (Fig. 6A) . Although UIS3 and UIS4 are required only during LS development, both are highly expressed already at the sporozoite stage [6, 7, 13, 31, 32] . UIS4 protein could be detected in slarp(-) sporozoites by immunofluorescence, but the labelling was consistently less intense than in WT sporozoites (Fig. 6B) .
Furthermore, RT-qPCR demonstrated a ,20 fold decrease of UIS4 transcript abundance in slarp(-) salivary gland sporozoites (Fig. 6C ). As observed with invaded parasites, expression of UIS3 and EXP1 was also reduced in slarp(-) sporozoites collected from infected mosquito salivary glands, although to a lesser extent (,3 fold and ,2 fold, respectively) (Fig. 6C) . Importantly, expression of several other genes was not significantly altered, including HSP70 and genes involved in sporozoite invasion (TRAP and apical membrane antigen-1, AMA1) or transmigration (sporozoite protein essential for cell traversal, SPECT) (Fig. 6C) . Altogether these results demonstrate that the lack of SLARP causes a selective and severe defect in expression of sporozoite genes involved in subsequent LS development.
Immunization with SLARP-deficient sporozoites confers limited protective immunity against P. berghei infection in C57BL/6 mice
Several studies have demonstrated that immunization with GAPs can induce protective immune responses against sporozoite infection in mice [6, 7, 8, 13, 33] . Because genetic attenuation offers several advantages, notably in terms of reproducibility and stability of attenuation, GAPs constitute an interesting alternative for whole parasite vaccine approaches [34] . One essential requirement for a malaria GAP-based vaccine is the absence of breakthrough infections caused by the parasites used for immunization. Since slarp(-) sporozoites never cause blood stage infections ( Table 2) , they make interesting candidates as GAP vaccines. To test whether SLARP-deficient parasites are capable of inducing protective immunity, we immunized C57BL/6 mice with different doses of slarp(-) sporozoites, administered either by intravenous injection or through exposure to infective mosquito bites. Mice immunized with 50,000 slarp(-) sporozoites followed by two boost injections of 25,000 sporozoites were fully protected when challenged with WT parasites 6 weeks after the last boost (Table 3) . However, protection rapidly decreased over time, since challenge 16 weeks after the last boost resulted in 40% protection only ( Table 3) . Reducing the dose of sporozoites used for immunization led to a progressive loss of protection. Sterile protection was only achieved in some of the mice immunized with 10,000 slarp(-) sporozoites, with a ,2 days delay in patency in non-protected animals as compared to naïve mice, suggesting only partial elimination of WT parasites in the liver ( Table 3) . No protection was observed in the groups immunized with 1,000 slarp(-) sporozoites or by mosquito bites, where all mice developed a blood stage infection after challenge, with only a minor delay in patency as compared to naïve mice ( Table 3) .
Discussion
Parasite replication in the liver is a prerequisite for the onset of malaria blood stage infection. Still, Plasmodium LS development remains poorly characterized on a molecular level. In this study, we identified a Plasmodium nuclear protein that is specifically expressed in sporozoites and LS and is vital for LS development. The developmental arrest observed in slarp(-) parasites is reminiscent of axenically cultured sporozoites that undergo initial transformation from elongated sporozoites to round early LS but fail to enter mitosis [35] . We hypothesize that this fundamental developmental switch is regulated, at least partially, by SLARP.
Our results demonstrate that the lack of SLARP causes a complete developmental arrest after sporozoite invasion. This phenotype is strikingly different from sporozoite gene knockouts reported so far [6, 7, 8, 26, 27, 36, 37, 38] . Slarp(-) sporozoites productively enter target cells under simultaneous formation of a replication-competent organelle, the PV. However, remodelling of the PVM is impaired as illustrated by the absence of two PVMresident proteins, UIS4 and EXP1, in mutant parasites. It is unlikely that the defect in UIS4 expression alone is the cause for the developmental arrest observed in SLARP-deficient parasites. Indeed, LS development is not completely blocked in UIS4-knockout parasites, as evidenced by partial growth in vitro and occurrence of blood stage infections after sporozoite inoculation [6] . We rather hypothesize that defects in expression of multiple LS proteins (including UIS4, UIS3 and EXP1) account for the severe phenotype observed with slarp(-) parasites.
Regulation of gene expression in Plasmodium is poorly understood. Based on the paucity of specific transcription factors identified in Plasmodium genomes and on comparative analysis of transcriptome and proteome data, it was suggested that posttranscriptional mechanisms may play a major role in regulation of gene expression in Plasmodium [18, 39, 40, 41, 42] . In this regard, translation repression was recently documented in sexual stages of the Plasmodium life cycle [43] , and may as well occur in other stages of the parasite life cycle. Nevertheless, the recent discovery of an Apetala-2 (AP2)-related family of transcription factors in Plasmodium raises the possibility that additional yet unidentified transcription regulators are also involved [44] .
Several lines of evidence strongly support a role for SLARP in the regulation of gene expression in sporozoites and early LS. First, SLARP is expressed in sporozoites and early/mid LS, as shown by RT-PCR, and a tagged version of SLARP fused to the red fluorescent protein mCherry localizes predominantly to the parasite nucleus. Additional studies using specific antibodies will be required to determine whether this nuclear localization of SLARP/mCherry reflects the normal distribution of the endogenous SLARP, or represents an artefact resulting from the fusion to mCherry. We favor the former, since NLS are present in SLARP but not mCherry protein sequence, and various other parasite lines with different mCherry tagged proteins generated in our lab do not display nuclear localization of the fusion protein (E.D. Putrianti, O. Silvie and K. Matuschewski, unpublished data). Second, we demonstrate here using quantitative PCR that deletion of SLARP causes a dramatic decrease in steady state transcript abundance for at least two genes, UIS3 and UIS4, in sporozoites collected from infected mosquito salivary glands or from HepG2 cells early after infection. This defect at the transcript level correlates with a dramatic reduction of the UIS4 protein content in invaded sporozoites, and to a lesser extent in salivary gland sporozoites, as shown by immunofluorescence.
Although UIS3 and UIS4 are essential only during LS development, they are highly expressed at the sporozoite stage [6, 7, 31, 32] , suggesting that sporozoites in the mosquito salivary glands are already prepared for the next LS developmental step. Similarly to UIS3 and UIS4, SLARP is expressed both in sporozoites and LS. While expression of UIS3 and UIS4 is dramatically diminished in slarp(-) parasites, expression of other sporozoites genes, involved in host cell traversal or productive invasion, is not affected, in good agreement with the absence of phenotypical defect during transmigration or host cell invasion by SLARP-deficient sporozoites. Based on these observations and the early developmental arrest of slarp(-) LS, we propose that SLARP functions as a specific regulator of the expression of genes involved at early steps of LS development, including UIS3 and UIS4 and probably additional yet unidentified genes.
The absence of EXP1 protein in slarp(-) LS probably involves a distinct mechanism, different from that responsible for UIS4 (and UIS3) depletion. First, EXP1 is expressed in blood stages, whereas SLARP is not, demonstrating that SLARP is not required for EXP1 expression. Second, our data show that abundance of EXP1 transcripts is only moderately affected in slarp(-) salivary gland as well as early invaded sporozoites. The fact that the protein EXP1 is not detected in sporozoites and very early LS (despite transcript presence) in WT parasites raises the possibility that EXP1 expression is regulated through post-transcriptional mechanisms. Since the lack of SLARP has only a modest effect on the expression of the EXP1 gene, as evidenced by quantitative RT-PCR, we believe that the absence of EXP1 protein in slarp(-) parasites probably reflects an early blockage in the LS developmental program at a step that precedes the onset of EXP1 translation activation. The lack of UIS4, which like EXP1 resides in the PVM, is probably not the cause of the defect in EXP1 expression in slarp(-) parasites since uis4(-) LS express EXP1 on their PVM normally [13] .
So far, we cannot ascertain whether SLARP directly modulates UIS3 and UIS4 transcriptional level or is involved in upstream events that govern UIS3 and UIS4 gene expression. Although SLARP is characterized by a high content in asparagine residues, a feature shared by most Plasmodium AP2 putative transcription factors [44] , as well as transcription regulators in other systems such as yeast [45] , it does not contain any known conserved DNA binding domain. Whether SLARP acts as a specific transcription factor or regulates the activity of a specific transcription factor is still unknown. Alternatively, we cannot exclude that SLARP regulates sporozoite gene expression by other mechanisms, such as chromatin level regulation or post-transcriptional control.
Altogether our results demonstrate that SLARP is a key regulator of Plasmodium LS development, and plays a critical role in gene expression regulation at an early step of the infection process. The identification of an asparagine-rich protein as a master regulator of LS development raises the possibility that other uncharacterized LCR-containing proteins may play a similar role in other stages of the parasite life cycle. This study opens new perspectives for the elucidation of gene expression regulation during the complex life cycle of the malaria parasite and for the characterization of molecular mechanisms of parasite development inside host cells.
A key finding is the limited capacity of slarp(-) parasites to induce long-lasting sterilizing immune responses, irrespective of their ability to productively enter their final target cells. In particular, immunization with low numbers of slarp(-) sporozoites did not induce protection, in sharp contrast with P36p(-) parasites generated in the same strain, which under similar conditions were shown to fully protect immunized animals [46] . Although the poor protective efficacy of SLARP-deficient parasites as compared to other GAPs needs to be confirmed in side-by-side experiments, we speculate that this failure to induce strong protection is due to the lack of expression of antigens involved in protective immune responses. The nature of protective antigens against Plasmodium LS still remains elusive. T cell responses against the main sporozoite surface protein, the circumsporozoite protein (CSP), are believed to play an important role (reviewed in [47] ). Nevertheless, two recent studies using transgenic mice or parasites clearly demonstrated that anti-CSP responses are dispensable for induction of sterile protection [48, 49] , suggesting that additional antigens, most likely LS antigens, are required [50] . We could show here that in the absence of SLARP, LS development aborts before the expression of the EXP1 antigen, which has been identified as a protective antigen in P. yoelii [51] . We hypothesize that the early and complete developmental arrest observed in SLARP-deficient parasites causes a severe narrowing of their antigenic repertoire, and consequently of the immune responses they elicit. Similar to over-irradiated sporozoites, which are also inferior in eliciting protective immunity [52] , slarp(-) parasites are perfectly attenuated. Although they represent ideal candidates for a safe GAP-based malaria vaccine high levels of protection may be very difficult to achieve. However, such a tool, an attenuated, yet poorly protective parasite, will be an important stepping stone towards the identification of protective liver stage antigens and immune effector cells. These studies can now be performed for the first time in side-by-side comparisons with fully protective GAPs generated in identical parasite strains [8, 46] . This path may ultimately lead to implementation of a safe metabolically active whole organism vaccine and new subunit strategies for antimalaria vaccine development.
Materials and Methods
Experimental animals, parasites and cell lines
Female NMRI mice, C57BL/6 mice and Sprague-Dawley (SD) rats were from Charles River Laboratories. All animal work was conducted in accordance with European regulations and approved by the state authorities (Regierungsprä sidium Karlsruhe). We used P. berghei ANKA clone 507 parasites, which constitutively express the green fluorescent protein (GFP) [21] . HepG2 cells (ATCC HB-8065) were cultured as described [53] . CGCGTTATGTATTTTTGTAAGAACTATTAAACC-39), SLARPrep3for (59-CCCAAGCTTCTTCACAAATATAATCAAA-CTTAGAACTGC-39) and SLARPrep4for (59-CGGGGTACC-GAACTTCAAAATCATCCATATTATATCC-39). B3D+ plasmid was obtained by inserting a 1214-bp fragment containing the 39 untranslated region of P. berghei dihydrofolate reductase/thymidylate synthase (DHFR/TS) into BamHI-EcoRI sites of the P. berghei targeting vector b3D.DT^H.^D (provided by Dr. Andrew Waters), which contains Toxoplasma gondii DHFR/TS as a selectable marker for resistance to pyrimethamine. Cloning of P. berghei SLARP 59 and 39 fragments into SacII-NotI and HindIII-KpnI sites, respectively, of B3D+ vector resulted into SLARPrepB3D+ plasmid. Parasites were transfected with SacII-KpnI digested SLARPrepB3D+ construct, using the NucleofectorH device (Amaxa GmbH) as described [21] , injected intravenously into naïve NMRI mice, and selected by pyrimethamine treatment in the drinking water. Clonal parasite populations were obtained by limiting dilution series and intravenous injection of one parasite in 15 recipient NMRI mice. Genotyping of WT and slarp(-) parasites was performed by PCR on parasite genomic DNA using primers specific for the wt locus (SLARPwtfor, 59-GAGACATAT-CAAATAATTACTACATACCACC-39; SLARPwtrev, 59-GGGG-TTCATAATTATATTTTCATTAGGGTCC-39), the 5' (SLARPreptest1for, 59-TCCCCGCGGCTAAAGTTCTCTATCGAA-TATAATATATACG-39; UTRrev, 59-AATTCCGGTGTGAAA-TACCGCACAGATGCG-39) and the 3' (TgPRO, 59-CGCATTA-TATGAGTTCATTTTACACAATCC-39; SLARPreptest2rev, 59-CGGGGTACCCACACGAATGTGTATGCTTATGAAGAT-GG-39) recombination events.
C-terminal fluorescent tagging
For fusion of the red fluorescent protein mCherry [20] to the Cterminus of SLARP, a 720-bp fragment corresponding to mCherry was first cloned into SpeI-BamHI sites of B3D+ plasmid, resulting in B3D+mCherry vector. A PCR fragment corresponding to the last 2500-bp of PbSLARP was amplified with primers SLARPtagfor (59-ATAAGAATGCGGCCGCTATGAGAAATA-CTGGGAATACCATTGAAGG-39) and SLARPtagrev (59-GGA-CTAGTATAAAATAAGAATCGATTCATTATTTCAAAATT-TATATGG-39), and cloned into NotI-SpeI sites of B3D+mCherry, resulting in the SLARPtagging construct. This targeting plasmid was linearized with HpaI and transfected as described above. Naïve recipient mice were injected with transfected parasites and treated with pyrimethamine to select for recombinant PbSLARP/ mCherry parasites. Integration of the construct in selected parasites was confirmed by PCR on genomic DNA using specific primer combinations. Expression of the SLARP/mCherry fusion protein was analyzed through direct detection of the red fluorescence of mCherry by confocal microscopy.
Reverse transcriptase-PCR
Total RNA was purified from sporozoites, infected HepG2 cells or infected erythrocytes using the RNeasy kit (Qiagen). Reverse transcription was performed using the RETROscript kit (Ambion). cDNA was used as template for PCR amplification with primers specific for P. berghei SLARP (SLARPcDNAfor, 59-TCCCCGCGGA-CAAGTTCAACAATCTTTTAATCACAGCGC-39; SLARPcDNArev, 59-ATAAGAATGCGGCCGCACACGAATGTGTATG-CTTATGAAGATGGGG-39), TRAP (TRAPcDNAfor, 59-CCC-GGATCCATGAAGCTCTTAGGAAATAG-39; TRAPcDNArev, 59-GTGTGGATCCTTCCTGACAAACTTTAGAAAG-39), UIS4 (UIS4cDNAfor, 59-ACCCATTGATGAGACAAACGATTCAA-AACC-39; UIS4cDNArev, 59-TCCATGTTATAAACGTTATT-TCCTTCACCC-39) or GAPDH (GAPDHcDNAfor, 59-ATGG-CAATAACAAAAGTCGGAATTAATGG-39; GAPDHcDNArev, 59-TGTGGATAGCCAAATCTAAAAGACGG-39).
Real time quantitative RT-PCR
Real time qPCR was performed on cDNA preparations using the ABI 7500 sequence detection system and Power SYBRH Green PCR Master Mix (Applied Biosystems), according to the manufacturer's instructions. Three independent cDNA samples were tested for each population. qPCR was performed in triplicates, with 1 cycle of 95uC for 15 min, followed by 40 cycles of 95uC for 15 s, 55uC for 15 s, and 60uC for 45 s. Standard curves were generated for all primers using WT cDNA serial dilutions and gave amplification efficiencies of 90-100%. Data were analyzed with the SDS 1.3.1 software (Applied Biosystems). Relative transcript abundance was determined using the 2 2DDCt method (User Bulletin 2, ABI). Expression data were normalized using the GFP gene. For analysis of HSP70, UIS3, UIS4, TRAP, AMA1 and SPECT expression by RT-qPCR, we used the same primers as reported by Amino et al. [24] . Additional primers include: GFP forward, 59-GATGGAAGCGTTCAACTAGCA-GACC-39; GFP reverse, 59-AGCTGTTACAAACTCAAGAAG-GACC-39;GAPDH forward, 59-AATTAAAGAAGCATCT-GAGGGTCCAC-39; GAPDH reverse, 59-TTGAATATCCC-CATTCATTGTCATACC-39; EXP1 forward, 59-AGGGAAGA-CATCCATTCCAAATTGG-39; EXP1 reverse, 59-TGAA-GATTTGGCATGTTAAGTGGTG-39.
Sporozoite infectivity in vivo
SD rats or C57BL/6 mice were injected intravenously with 100 ml of sporozoite suspension of WT or slarp(-) parasites isolated from the salivary glands of infected Anopheles stephensi mosquitoes, or exposed to 5-10 infected mosquito bites, as indicated. Infection was then monitored daily by examination of Giemsa-stained blood smears. The delay of patency was defined as the time before detection of at least one erythrocytic stage in the smears.
Phenotypic analysis of mutant parasites in vitro
For analysis of sporozoite cell traversal, HepG2 cells were incubated 3 hours at 37uC with sporozoites (5610 4 ) in the presence of 0.5 mg/ml fluorescein-conjugated dextran (Molecular Probes) [23] . Cells were then trypsinized and washed to remove extracellular sporozoites and dextran, and either analyzed by FACS to determine the percentage of dextran-positive cells, or plated in 8-chamber plastic Lab-Tek slides and further cultured at least 3 hours before analysis by fluorescence microscopy. To analyze productive infection and LS development, infected HepG2 cultures in Lab-Teks were incubated for 6-72 hours post-infection before analysis by immunofluorescence using primary antibodies against P. berghei CSP [54] , HSP-70 [55] , UIS4 [6] , or EXP1 [19] as indicated, and appropriate secondary antibodies (Molecular probes). Hoechst 33342 (Molecular Probes) was used to stain nuclei. Cholesterol staining with filipin (Sigma) was performed as described [56] . Images were acquired on a Zeiss LSM510 confocal system (Zeiss, Germany) equipped with visible and UV laser lines, and processed with Adobe Photoshop software (Adobe Systems Inc.).
Immunization and sporozoite challenge experiments C57BL/6 mice were immunized three times at 2 weeks intervals with slarp(-) sporozoites injected intravenously. Animals were immunized by intravenous injection of 1,000, 10,000 or 50,000 sporozoites, followed by two boosts of 1,000, 10,000 or 25,000, respectively. For immunization through mosquito bites, mice were exposed to the bites of 10 infected mosquitoes, three times at 2 weeks intervals. Immunized mice were challenged at least 3 weeks after the last boost by intravenous injection of 10,000 P. berghei ANKA WT sporozoites or exposure to the bites of 5 infected mosquitoes. Infection was monitored daily by examination of Giemsa-stained blood smears until day 21 post-challenge. Nonimmunized C57BL/6 mice were included in all challenge experiments to control WT sporozoite infectivity.
Accession numbers
The nucleotide sequences reported in this paper have been submitted to the Genbank database with the accession numbers EU579524 and EU579525.
